CURI vs MPU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 14, 2026

CURI

47.7
AI Score
VS
MPU Wins

MPU

52.0
AI Score

Investment Advisor Scores

CURI

48score
Recommendation
HOLD

MPU

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CURI MPU Winner
Revenue 38.41M 20.91M CURI
Net Income 7.55M -14.79M CURI
Net Margin 19.7% -70.7% CURI
Operating Income 7.64M -13.62M CURI
ROE 18.2% -39.5% CURI
ROA 11.2% -34.6% CURI
Total Assets 67.47M 42.73M CURI
Cash 5.38M 9.77M MPU

Relative Price Performance (Last 90 Days)

CURI 1M: -30.1% · 3M: +9.8% MPU 1M: -3.8% · 3M: -54.4%

Current Technical Phase

CURI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 51

RSI (14): 51.1 · Price: $2.79

MPU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.9%), weak momentum, RSI 45

RSI (14): 44.8 · Price: $0.19

Fundamentals Snapshot

Metric CURI MPU
Market Cap
Forward P/E 9.0 3.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% -0.5%
Gross Margin 0.6% 0.6%
Operating Margin 0.4% -3.8%
EPS -0.01 -0.75
Dividend Yield 0.12%

Frequently Asked Questions

Based on our detailed analysis, MPU is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.